UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

No, the glycaemic target in the critically ill should not be <=6.1 mmol/l

Diabetologia, 2008-06, Vol.51 (6), p.916-920

2008

Volltextzugriff (PDF)

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

Annals of internal medicine, 1998-07, Vol.129 (1), p.38

1998

Volltextzugriff (PDF)

Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery

The journal of clinical endocrinology and metabolism, 1992-08, Vol.75 (2), p.590-595

1992

Volltextzugriff (PDF)

Rosiglitazone and liver failure

Annals of internal medicine, 2000-09, Vol.133 (5), p.393

2000

Volltextzugriff (PDF)

Estrogen-induced pancreatitis after discontinuation of concomitant medroxyprogesterone therapy

The American journal of medicine, 1997-04, Vol.102 (4), p.416-417

1997

Volltextzugriff (PDF)

Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine

Annals of internal medicine, 1987-10, Vol.107 (4), p.517

Isley, W L

1987

Volltextzugriff (PDF)

Dietary components that regulate serum somatomedin-C concentrations in humans

The Journal of clinical investigation, 1983-02, Vol.71 (2), p.175-182

1983

Volltextzugriff (PDF)

Clinical trial evidence for the cardioprotective effects of omega-3 fatty acids

Current atherosclerosis reports, 2001-03, Vol.3 (2), p.174-179

2001

Volltextzugriff (PDF)

Hepatotoxicity of thiazolidinediones

Expert opinion on drug safety, 2003-11, Vol.2 (6), p.581-586

Isley, William L

2003

Volltextzugriff (PDF)

Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content

JPEN. Journal of parenteral and enteral nutrition, 1984-07, Vol.8 (4), p.407-411

1984

Volltextzugriff (PDF)

163 POSTPRANDIAL FREE FATTY ACID METABOLISM IN NORMAL, DYSLIPIDEMIC AND TYPE 2 DIABETIC SUBJECTS: A RELATIONSHIP TO HEPATIC TRIGLYCERIDE METABOLISM?

Journal of investigative medicine, 2005-01, Vol.53 (1), p.S106-S106

2005

Volltextzugriff (PDF)

How big a dose of levothyroxine?

Postgraduate medicine, 1993-12, Vol.94 (8), p.38, 45-45

Isley, W L

1993

Volltextzugriff (PDF)

Hepatotoxicity of thiazolidinediones

Diabetes, obesity & metabolism, 2001-12, Vol.3 (6), p.389-392

2001

Volltextzugriff (PDF)

Ketoacidosis during a Low-Carbohydrate Diet

The New England journal of medicine, 2006-01, Vol.354 (1), p.97-98

2006

Volltextzugriff (PDF)

Thyrotoxicosis in the Critically Ill

Critical care clinics, 1991-01, Vol.7 (1), p.57-74

1991

Volltextzugriff (PDF)

Efficacy and safety of reformulated, micronized glyburide tablets in patients with non-insulin-dependent diabetes mellitus : a multicenter, double-blind, randomized trial

Clinical therapeutics, 1993-09, Vol.15 (5), p.788-796

1993

Volltextzugriff (PDF)

Somatomedin-C as a Nutritional Marker in Traumatized Patients

Critical care medicine, 1990-07, Vol.18 (7), p.795-795

1990

Volltextzugriff (PDF)

Systemic and forearm triglyceride metabolism: Fate of lipoprotein lipase-generated glycerol and free fatty acids

Diabetes (New York, N.Y.), 2004-03, Vol.53 (3), p.521-527

2004

Volltextzugriff (PDF)

Rifampicin-induced adrenal insufficiency in the acquired immunodeficiency syndrome: difficulties in diagnosis and treatment

Postgraduate medical journal, 1988-05, Vol.64 (751), p.405-406

1988

Volltextzugriff (PDF)

Thyroid scanning in patients with suspected thyroid disease

Annals of internal medicine, 1985-02, Vol.102 (2), p.209

1985

Volltextzugriff (PDF)

Dialyzable Factor in Human Serum of Platelet Origin Stimulates Endothelial Cell Replication and Growth

Proceedings of the National Academy of Sciences - PNAS, 1983-03, Vol.80 (6), p.1641-1645

1983

Volltextzugriff (PDF)

Thyroid dysfunction in the severely ill and elderly: Forget the classic signs and symptoms

Postgraduate medicine, 1993-09, Vol.94 (3), p.111-128

Isley, William L.

1993

Volltextzugriff (PDF)

Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: Effects of insulin sensitization therapy

Diabetes (New York, N.Y.), 2003-03, Vol.52 (3), p.675-681

2003

Volltextzugriff (PDF)

Review: glucosidase inhibitors improve glycaemic control but have uncertain effects on patient-important outcomes in type 2 diabetes

Evidence-based medicine (English ed.), 2005-12, Vol.10 (6), p.174-174

Isley, W. L

2005

Volltextzugriff (PDF)

Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/1 and 6.1 mmol/1. Commentary

Diabetologia, 2008, Vol.51 (6)

2008

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(72)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Humans
(48)
Life Sciences & Biomedicine
(47)
Female
(29)
Biological And Medical Sciences
(22)
General & Internal Medicine
(21)
Adult
(19)
Male
(19)
Medical Sciences
(19)
Medicine, General & Internal
(19)
Middle Aged
(18)
Aged
(13)
Endocrinology & Metabolism
(9)
Pharmacology. Drug Treatments
(8)
Thiazolidinediones
(6)
Diabetes Mellitus, Type 2 - Drug Therapy
(5)
Fundamental And Applied Biological Sciences. Psychology
(4)
Kinetics
(4)
Mortality
(4)
Blood Glucose - Metabolism
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

No, the glycaemic target in the critically ill should not be <=6.1 mmol/l

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery

Rosiglitazone and liver failure

Estrogen-induced pancreatitis after discontinuation of concomitant medroxyprogesterone therapy

Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine

Dietary components that regulate serum somatomedin-C concentrations in humans

Clinical trial evidence for the cardioprotective effects of omega-3 fatty acids

Hepatotoxicity of thiazolidinediones

Changes in plasma somatomedin-C in response to ingestion of diets with variable protein and energy content

163 POSTPRANDIAL FREE FATTY ACID METABOLISM IN NORMAL, DYSLIPIDEMIC AND TYPE 2 DIABETIC SUBJECTS: A RELATIONSHIP TO HEPATIC TRIGLYCERIDE METABOLISM?

How big a dose of levothyroxine?

Hepatotoxicity of thiazolidinediones

Ketoacidosis during a Low-Carbohydrate Diet

Thyrotoxicosis in the Critically Ill

Efficacy and safety of reformulated, micronized glyburide tablets in patients with non-insulin-dependent diabetes mellitus : a multicenter, double-blind, randomized trial

Somatomedin-C as a Nutritional Marker in Traumatized Patients

Systemic and forearm triglyceride metabolism: Fate of lipoprotein lipase-generated glycerol and free fatty acids

Rifampicin-induced adrenal insufficiency in the acquired immunodeficiency syndrome: difficulties in diagnosis and treatment

Thyroid scanning in patients with suspected thyroid disease

Dialyzable Factor in Human Serum of Platelet Origin Stimulates Endothelial Cell Replication and Growth

Thyroid dysfunction in the severely ill and elderly: Forget the classic signs and symptoms

Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: Effects of insulin sensitization therapy

Review: glucosidase inhibitors improve glycaemic control but have uncertain effects on patient-important outcomes in type 2 diabetes

Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/1 and 6.1 mmol/1. Commentary

Suchergebnisse filtern